Prescription drug misuse and abuse is a complex problem, affecting individuals of all ages and in all communities across the country and its territories. Prescription drugs include pain relievers, tranquilizers, stimulants, and sedatives. Prescription drug misuse or abuse describes situations in which individuals use these drugs in ways they were not intended: either without a prescription, inconsistent with the doctor's instructions, or only for the experience or feeling they produce.
SAMHSA's CAPT is working with states, tribes, jurisdictions, and communities to develop and implement strategies to prevent the misuse and abuse of prevention drugs. Below are resources to assist in that effort.
- Beyond the Warning Label: Identifying and Prioritizing Risk and Protective Factors for Non-Medical Use of Prescription Drugs. This is the first webinar in a two-part series that offers PFS II grantees an introduction to the process of identifying and prioritizing risk and protective factors that contribute to non-medical use of prescription drugs (NMUPD).
- What’s the Prescription? Strategies and Interventions to Prevent the Non-Medical Use of Prescription Drugs. This is the second webinar in a two-part series that offers PFS II grantees a chance to explore current research on the non-medical use of prescription drugs, and implications for the implementation of evidence-based strategies.
Decision Support Tools:
- Factors Associated with the Non-Medical Use of Prescription Drugs. Using a social-ecological framework, this document identifies risk and protective factors related to the nonmedical use of prescription drugs (NMUPD) based on articles published between 2006 and 2012.
- Strategies to Prevent the Non-Medical Use of Prescription Drugs: Using Prevention Research to Guide Prevention Practice. This inventory includes an overview of the relevant literature, descriptions of individual studies in, and guidelines for using the document to inform prevention planning.
Data Sources Related to the Non-Medical Use of Prescription Drugs:
- Sources of Consumption Data Related to Non-medical Use of Prescription Drugs. This chart lists state- and local-level sources of consumption data, including source descriptions, web addresses, relevant survey questions, and types of online analysis available.
- Sources of Consequence Data Related to Non-medical Use of Prescription Drugs. This chart lists state- and local-level sources of consequence data, including source descriptions, web addresses, and types of online analysis available.
- Other Sources of Data Related to Non-medical Use of Prescription Drugs. This chart includes four data sources: the National Forensic Laboratory Information System, the Automation of Reports and Consolidated Orders System, the High Intensity Drug Trafficking Area, and the Prescription Drug Monitoring Program Center of Excellence.
Preventing Prescription Abuse in the Workplace:
- Evidence-Based and Promising Workplace Programs to Prevent Prescription Drug Abuse (Archived Webinar). Sponsored by SAMHSA's Preventing Prescription Abuse in the Workplace (PAW) Project, this webinar explores evidence-based and promising programs designed to prevent prescription drug abuse in the workplace. Presenters from four model programs explore key components of their programs and share their successes.
- Preventing Prescription Abuse in the Workplace (PAW): Prescription Drug Abuse Webinar (Slide Presentation). This webinar is the first in a series on prescription drug abuse prevention. It highlights the four major subtypes of non-medical drug use, distinguishes between the types of prescription drugs that are most abused, and identifies the populations at-risk for different types of prescription drug abuse and the risk factors for various consumption patterns.
- Prescription Drug Abuse in the Workplace. Also developed by SAMHSA's Preventing PAW Technical Assistance Program, this fact sheet reviews the safety of prescription drugs, the extent of the problem and those affected in the workplace, and opportunities for prevention and treatment.
Developed under the Substance Abuse and Mental Health Services Administration’s Center for the Application of Prevention Technologies contract (Reference #HHSS277200800004C).